2 results
Approved WMOCompleted
Primary Objective: - to evaluate the pharmacokinetic (PK) parameters (AUC0-t, AUC0-inf, Cmax, C24hr, Tmax, and apparent t*) of MK-3682 and its circulating metabolites (IDX20664 and IDX23267), MK-5172, and MK-8742 following administration of two…
Approved WMOCompleted
To evaluate the safety, tolerability and pharmacokinetics of ascending single and multiple doses of CH-4051.